[ad_1]
Following US President Donald Trump's criticism of high drug prices in America, German drug companies are also making concessions. For example, Darmstadt's supplier, Merck, refrains from increasing drug prices for the time being. "We are currently forecasting no price increases in the United States for the remainder of the year 2018," Merck said.
Bayer is also Trump pressure: They signed an agreement not to raise the prices of all prescription drugs by the end of the year the group explained. US Health Minister Alex Azar has been "personally" informed, Bayer pointed out.
An badyst sees a corporate precautionary measure
Trump has repeatedly criticized the high cost of the American health care system. Recently, several pharmaceutical giants such as Roche, Novartis and Pfizer have reacted and renounced rising prices in the United States. The American company Merck & Co has announced prices even lower. After giving in, Trump thanked the companies for the Twitter short message service.
Analysts see fast leases as a precautionary measure by pharmaceutical companies. "They want to get out of Trump's fire line," says Ulrich Huwald, an badyst at private bank Mr M. Warburg. High drug prices are a political issue: "In the fall, there are mid-term elections for which Trump needs success."
Source link
